BioVaxys Technology Corp. (CSE: BIOV)
Canada
· Delayed Price · Currency is CAD 0.0600
-0.0050 (-7.69%)
Jan 21, 2025, 9:30 AM EST
BioVaxys Technology Market Cap
BioVaxys Technology has a market cap or net worth of CAD 15.70 million as of January 21, 2025. Its market cap has increased by 430.20% in one year.
Market Cap
15.70M
Enterprise Value
15.29M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since October 6, 2020, BioVaxys Technology's market cap has decreased from 27.06M to 15.70M, a decrease of -41.99%. That is a compound annual growth rate of -11.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2025 | 17.12M | 3.91% |
| Dec 31, 2024 | 16.48M | 127.10% |
| Dec 29, 2023 | 7.26M | -47.89% |
| Dec 30, 2022 | 13.92M | -26.37% |
| Dec 31, 2021 | 18.91M | 32.10% |
| Dec 31, 2020 | 14.32M | -47.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries | 2.54B |
| Curaleaf Holdings | 1.63B |
| WELL Health Technologies | 1.61B |
| dentalcorp Holdings | 1.54B |
| Trulieve Cannabis | 1.37B |
| Sienna Senior Living | 1.26B |
| Cronos Group | 1.09B |
| Extendicare | 856.37M |